Conatus Pharmaceuticals Receives $5,000,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b649cad8-9789-4897-a5ad-13d9792d0258&Preview=1 -
Date
10/29/2010 -
Company Name
Conatus Pharmaceuticals -
Mailing Address
4365 Executive Drive San Diego, CA 92121 -
Company Description
The Conatus team pioneered the science of apoptosis and the clinical development of pan caspase inhibitors, validating this first-in-class technology. Conatus has well established relationships with key opinion leaders in the fields of hepatology, infectious disease and inflammation. -
Website
http://www.conatuspharma.com -
Transaction Type
Debt -
Transaction Amount
$5,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
